← Back to headlines

Protagonist, J&J’s oral IL-23 psoriasis data strong (but short)

This story is reported by BioWorld News. Read what other outlets are saying below, then open the original report for full details.

Protagonist, J&J’s oral IL-23 psoriasis data strong (but short) · NabkaNews